The Journal of Molecular Diagnostics


Publication Venue For

  • Evaluation, Validation and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine. 2019
  • Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.  19:475-484. 2017
  • Current and Emerging Molecular Tests for Human Papillomavirus–Related Neoplasia in the Genomic Era.  19:366-377. 2017
  • Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.  19:417-426. 2017
  • Molecular oncology testing in resource-limited settings.  16:601-611. 2014
  • Development of a genomic DNA reference material panel for rett syndrome (MECP2-related disorders) genetic testing.  16:273-279. 2014
  • Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens.  15:485-497. 2013
  • Certification in molecular pathology in the United States: an update from the Association for Molecular Pathology Training and Education Committee. 2012
  • Molecular methods for the detection of mycoplasma and ureaplasma infections in humans: A paper from the 2011 William Beaumont Hospital symposium on molecular pathology.  14:437-450. 2012
  • A virtual pyrogram generator to resolve complex pyrosequencing results.  14:149-159. 2012
  • Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: Superior results compared with microsatellite analysis.  13:541-548. 2011
  • Δ-PCR, a simple method to detect translocations and insertion/deletion mutations.  13:85-92. 2011
  • Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array. Application to Hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma.  8:76-83. 2006
  • Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA.  7:171-182. 2005
  • Reproducibility, fidelity, and discriminant validity of mRNA amplification for microarray analysis from primary hematopoietic cells.  7:48-56. 2005
  • International Standard Serial Number (issn)

  • 1525-1578
  • Electronic International Standard Serial Number (eissn)

  • 1943-7811